Insider Trading - Kumar Ramesh
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-04-26 Purchase | 2017-04-28 3:03 pm | Onconova Therapeutics Inc. | ONTX | Kumar Ramesh CEO | 23,810 | $2.1 | $50,001 | 102,227 (Direct) | View |
| 2021-04-19 Sale | 2021-04-21 4:16 pm | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $5.33 | $39,975 | 46,500 (Direct) | View |
| 2021-07-19 Sale | 2021-07-21 4:04 pm | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $6.4 | $48,000 | 39,000 (Direct) | View |
| 2021-10-18 Sale | 2021-10-20 6:56 pm | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $8.13 | $60,975 | 31,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-12-15 Option Award | 2016-12-19 4:34 pm | N/A 2026-12-15 | Onconova Therapeutics Inc. | ONTX | Kumar Ramesh CEO | 12,673 | $0 | 12,673 (Direct) | View |
| 2017-01-17 Option Award | 2017-01-19 1:32 pm | N/A 2027-01-17 | Onconova Therapeutics Inc. | ONTX | Kumar Ramesh CEO | 44,027 | $0 | 44,027 (Direct) | View |
| 2018-01-03 Option Award | 2018-01-05 4:54 pm | N/A 2028-01-03 | Onconova Therapeutics Inc. | ONTX | Kumar Ramesh CEO | 64,885 | $0 | 64,885 (Direct) | View |
| 2018-02-23 Option Award | 2018-02-27 5:26 pm | 2018-02-23 2028-02-23 | Onconova Therapeutics Inc. | ONTX | Kumar Ramesh CEO | 73,220 | $0 | 73,220 (Direct) | View |
| 2018-07-26 Option Award | 2018-07-30 5:25 pm | N/A 2028-07-26 | Onconova Therapeutics Inc. | ONTX | Kumar Ramesh CEO | 1,065,600 | $0 | 1,065,600 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 8:17 pm | N/A 2030-01-02 | Ocugen Inc. | OCGN | Kumar Ramesh Director | 54,000 | $0 | 54,000 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-04 5:43 pm | N/A 2031-01-01 | Ocugen Inc. | OCGN | Kumar Ramesh Director | 126,000 | $0 | 126,000 (Direct) | View |
| 2021-04-19 Exercise | 2021-04-21 4:16 pm | N/A 2030-01-02 | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $0 | 46,500 (Direct) | View |
| 2021-04-19 Exercise | 2021-04-21 4:16 pm | N/A N/A | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $0.51 | 46,500 (Direct) | View |
| 2021-07-19 Exercise | 2021-07-21 4:04 pm | N/A 2030-01-02 | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $0 | 39,000 (Direct) | View |
| 2021-07-19 Exercise | 2021-07-21 4:04 pm | N/A N/A | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $0.51 | 39,000 (Direct) | View |
| 2021-10-18 Exercise | 2021-10-20 6:56 pm | N/A 2030-01-02 | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $0 | 31,500 (Direct) | View |
| 2021-10-18 Exercise | 2021-10-20 6:56 pm | N/A N/A | Ocugen Inc. | OCGN | Kumar Ramesh Director | 7,500 | $0.51 | 31,500 (Direct) | View |